IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Gastric / Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospitalmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Gastric / Gastroesophageal Junction Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TRASTUZUMAB Shanghai Zhongshan Hospital | Phase 3 | BB |
Docetaxel Shanghai Zhongshan Hospital | Phase 2 | B |
okn4395 Epkin | Phase 1 | CC |
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →